Schrader; Thomas O.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schrader; Thomas O..The latest application filed is for "5-ht2c receptor agonists and compositions and methods of use".

Company Profile

3.7.9

Schrader; Thomas O. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5-ht2c Receptor Agonists And Compositions And Methods Of Use App 20210214355 - Semple; Graeme ; et al.	2021-07-15
5-HT2C receptor agonists and compositions and methods of use Grant 10,836,764 - Semple , et al. November 17, 2	2020-11-17
5-ht2c Receptor Agonists And Compositions And Methods Of Use App 20190225612 - Semple; Graeme ; et al.	2019-07-25
Processes For The Preparation Of S1p1 Receptor Modulators And Crystalline Forms Thereof App 20150284399 - Jones; Robert M. ; et al.	2015-10-08
Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof Grant 9,085,581 - Jones , et al. July 21, 2	2015-07-21
3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders Grant 8,507,473 - Boatman , et al. August 13, 2	2013-08-13
Processes For The Preparation Of S1p1 Receptor Modulators And Crystalline Forms Thereof App 20120329848 - Jones; Robert M. ; et al.	2012-12-27
3h-imidazo[4,5-b]pyridin-5-ol Derivatives Useful In The Treatment Of Gpr81 Receptor Disorders App 20110172209 - Boatman; P. Douglas ; et al.	2011-07-14
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof Grant 7,612,106 - Boatman , et al. November 3, 2	2009-11-03
Fused Pyrazole Derivatives And Methods Of Treatment Of Metabolic-related Disorders Thereof App 20090258892 - Boatman; P. Douglas ; et al.	2009-10-15
Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof App 20070254903 - Boatman; P. Douglas ; et al.	2007-11-01
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof Grant 7,241,792 - Boatman , et al. July 10, 2	2007-07-10
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof App 20070073062 - Boatman; P. Douglas ; et al.	2007-03-29
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof App 20060205955 - Boatman; P. Douglas ; et al.	2006-09-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.